Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Quickscan assesses risk factors of long-term sickness absence: A cross-sectional (factorial) construct validation study.

Goorts K, Vandenbroeck S, Vander Elst T, Rusu D, Du Bois M, Decuman S, Godderis L.

PLoS One. 2019 Jan 11;14(1):e0210359. doi: 10.1371/journal.pone.0210359. eCollection 2019.

2.

A prospective, longitudinal study evaluating the baseline six-minute walk test as an individual reference value in systemic sclerosis patients.

Vandecasteele E, Melsens K, De Keyser F, De Pauw M, Deschepper E, Decuman S, Piette Y, Thevissen K, Brusselle G, Smith V.

Clin Exp Rheumatol. 2018 Jul-Aug;36 Suppl 113(4):95-101. Epub 2018 Aug 28.

PMID:
30183593
3.

The efficacy and efficiency of Disability Management in job-retention and job-reintegration. A systematic review.

Lefever M, Decuman S, Perl F, Braeckman L, Van de Velde D.

Work. 2018;59(4):501-534. doi: 10.3233/WOR-182709. Review.

PMID:
29733052
4.

Nailfold capillaroscopy in systemic lupus erythematosus: A systematic review and critical appraisal.

Cutolo M, Melsens K, Wijnant S, Ingegnoli F, Thevissen K, De Keyser F, Decuman S, Müller-Ladner U, Piette Y, Riccieri V, Ughi N, Vandecasteele E, Vanhaecke A, Smith V.

Autoimmun Rev. 2018 Apr;17(4):344-352. doi: 10.1016/j.autrev.2017.11.025. Epub 2018 Feb 8. Review.

PMID:
29427827
5.

Two years follow-up of an open-label pilot study of treatment with rituximab in patients with early diffuse cutaneous systemic sclerosis.

Melsens K, Vandecasteele E, Deschepper E, Badot V, Blockmans D, Brusselle G, De Langhe E, De Pauw M, Debusschere C, Decuman S, Deroo L, Houssiau F, Lenaerts J, Piette Y, Thevissen K, Vanthuyne M, Westhovens R, Wijnant S, De Keyser F, Smith V.

Acta Clin Belg. 2018 Apr;73(2):119-125. doi: 10.1080/17843286.2017.1372244. Epub 2017 Sep 11.

PMID:
28891418
6.

The role of endothelial cells in the vasculopathy of systemic sclerosis: A systematic review.

Mostmans Y, Cutolo M, Giddelo C, Decuman S, Melsens K, Declercq H, Vandecasteele E, De Keyser F, Distler O, Gutermuth J, Smith V.

Autoimmun Rev. 2017 Aug;16(8):774-786. doi: 10.1016/j.autrev.2017.05.024. Epub 2017 May 29. Review.

PMID:
28572048
7.

Screening for pulmonary arterial hypertension in an unselected prospective systemic sclerosis cohort.

Vandecasteele E, Drieghe B, Melsens K, Thevissen K, De Pauw M, Deschepper E, Decuman S, Bonroy C, Piette Y, De Keyser F, Brusselle G, Smith V.

Eur Respir J. 2017 May 11;49(5). pii: 1602275. doi: 10.1183/13993003.02275-2016. Print 2017 May.

8.

Six-minute walk test in or out in evaluation of systemic sclerosis patients?

Vandecasteele E, Thevissen K, Melsens K, De Keyser F, De Pauw M, Deschepper E, Decuman S, Piette Y, Brusselle G, Smith V.

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):122-129. Epub 2017 Feb 15.

PMID:
28229829
9.

Assessment of sensitivity to change of the European Scleroderma Study Group activity index.

Melsens K, De Keyser F, Decuman S, Brusselle G, De Pauw M, Deschepper E, De Wilde K, Elewaut D, Piette Y, Vandecasteele E, Smith V.

Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):148-151. Epub 2016 Jul 18.

PMID:
27463733
10.

Disease activity indices in systemic sclerosis: a systematic literature review.

Melsens K, De Keyser F, Decuman S, Piette Y, Vandecasteele E, Smith V.

Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):186-192. Epub 2016 Jul 6. Review.

11.

Stabilization of Microcirculation in Patients with Early Systemic Sclerosis with Diffuse Skin Involvement following Rituximab Treatment: An Open-label Study.

Smith V, Pizzorni C, Riccieri V, Decuman S, Brusselle G, DE Pauw M, Deschepper E, Piette Y, Ruaro B, Sulli A, Vandecasteele E, Melsens K, DE Keyser F, Cutolo M.

J Rheumatol. 2016 May;43(5):995-6. doi: 10.3899/jrheum.151018. No abstract available.

PMID:
27134280
12.

The heart and pulmonary arterial hypertension in systemic sclerosis.

Vandecasteele EH, De Pauw M, Brusselle G, Decuman S, Piette Y, De Keyser F, Smith V.

Acta Clin Belg. 2016 Feb;71(1):1-18. doi: 10.1080/17843286.2015.1108538. Epub 2016 Feb 5. Review.

PMID:
27075793
13.

Six-minute walk test in systemic sclerosis: A systematic review and meta-analysis.

Vandecasteele E, De Pauw M, De Keyser F, Decuman S, Deschepper E, Piette Y, Brusselle G, Smith V.

Int J Cardiol. 2016 Jun 1;212:265-73. doi: 10.1016/j.ijcard.2016.03.084. Epub 2016 Mar 25. Review.

PMID:
27057932
14.

Reliability of the quantitative assessment of peripheral blood perfusion by laser speckle contrast analysis in a systemic sclerosis cohort.

Lambrecht V, Cutolo M, De Keyser F, Decuman S, Ruaro B, Sulli A, Deschepper E, Smith V.

Ann Rheum Dis. 2016 Jun;75(6):1263-4. doi: 10.1136/annrheumdis-2015-208857. Epub 2016 Mar 22. No abstract available.

PMID:
27005682
15.

An EULAR study group pilot study on reliability of simple capillaroscopic definitions to describe capillary morphology in rheumatic diseases.

Smith V, Beeckman S, Herrick AL, Decuman S, Deschepper E, De Keyser F, Distler O, Foeldvari I, Ingegnoli F, Müller-Ladner U, Riccieri V, Riemekasten G, Sulli A, Voskuyl A, Cutolo M; EULAR study group on microcirculation.

Rheumatology (Oxford). 2016 May;55(5):883-90. doi: 10.1093/rheumatology/kev441. Epub 2016 Feb 3.

PMID:
26843483
16.

Comparison of the Belgian Rheumatoid Arthritis Disability Assessment and Health Assessment Questionnaires as Tools to Predict the Need for Support Measures in Patients with Rheumatoid Arthritis.

Janssens X, Decuman S, De Keyser F; Belgian Rheumatoid Arthritis Disability Assessment study group.

PLoS One. 2016 Jan 22;11(1):e0146688. doi: 10.1371/journal.pone.0146688. eCollection 2016.

17.

Content of non-pharmacological care for systemic sclerosis and educational needs of European health professionals: a EUSHNet survey.

Willems LM, Redmond AC, Stamm TA, Boström C, Decuman S, Kennedy AT, Brozd J, Roškar S, Smith V, Vliet Vlieland TP, van den Ende CH.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S153-9. Epub 2015 Sep 1.

PMID:
26339894
18.

Factors influencing the occupational trajectory of patients with systemic sclerosis: a qualitative study.

Decuman S, Smith V, Grypdonck M, De Keyser F, Verhaeghe S.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S26-30. Epub 2015 Mar 20.

PMID:
25797634
19.

Methods for the morphological and functional evaluation of microvascular damage in systemic sclerosis.

Ruaro B, Smith V, Sulli A, Decuman S, Pizzorni C, Cutolo M.

Korean J Intern Med. 2015 Jan;30(1):1-5. doi: 10.3904/kjim.2015.30.1.1. Epub 2014 Dec 30. Review.

20.

Work participation in patients with systemic sclerosis: a systematic review.

Decuman S, Smith V, Verhaeghe ST, Van Hecke A, De Keyser F.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-206-13. Epub 2014 Nov 5. Review.

PMID:
25372803
21.

Assessment of activity limitations with the health assessment questionnaire predicts the need for support measures in patients with rheumatoid arthritis: a multicenter observational study.

Janssens X, Decuman S, De Keyser F; Belgian Rheumatoid Arthritis Disability Assessment Study Group.

PLoS One. 2014 Sep 4;9(9):e106749. doi: 10.1371/journal.pone.0106749. eCollection 2014.

22.

Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development.

Lambrecht S, Smith V, De Wilde K, Coudenys J, Decuman S, Deforce D, De Keyser F, Elewaut D.

Arthritis Rheumatol. 2014 Feb;66(2):418-27. doi: 10.1002/art.38241.

23.

Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis.

Smith V, Riccieri V, Pizzorni C, Decuman S, Deschepper E, Bonroy C, Sulli A, Piette Y, De Keyser F, Cutolo M.

J Rheumatol. 2013 Dec;40(12):2023-8. doi: 10.3899/jrheum.130528. Epub 2013 Oct 15.

PMID:
24128778
24.
25.

Two-year results of an open pilot study of a 2-treatment course with rituximab in patients with early systemic sclerosis with diffuse skin involvement.

Smith V, Piette Y, van Praet JT, Decuman S, Deschepper E, Elewaut D, De Keyser F.

J Rheumatol. 2013 Jan;40(1):52-7. doi: 10.3899/jrheum.120778. Epub 2012 Nov 1.

PMID:
23118116
26.

Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study.

Smith V, Decuman S, Sulli A, Bonroy C, Piettte Y, Deschepper E, de Keyser F, Cutolo M.

Ann Rheum Dis. 2012 Oct;71(10):1636-9. doi: 10.1136/annrheumdis-2011-200780. Epub 2012 Mar 8.

PMID:
22402146
27.

Work participation and work transition in patients with systemic sclerosis: a cross-sectional study.

Decuman S, Smith V, Verhaeghe S, Deschepper E, Vermeiren F, De Keyser F.

Rheumatology (Oxford). 2012 Feb;51(2):297-304. doi: 10.1093/rheumatology/ker288. Epub 2011 Oct 4.

PMID:
21972420
28.

Nailfold capillaroscopy for day-to-day clinical use: construction of a simple scoring modality as a clinical prognostic index for digital trophic lesions.

Smith V, De Keyser F, Pizzorni C, Van Praet JT, Decuman S, Sulli A, Deschepper E, Cutolo M.

Ann Rheum Dis. 2011 Jan;70(1):180-3. doi: 10.1136/ard.2010.132431. Epub 2010 Oct 21.

PMID:
20971717
29.

Reliability of the qualitative and semiquantitative nailfold videocapillaroscopy assessment in a systemic sclerosis cohort: a two-centre study.

Smith V, Pizzorni C, De Keyser F, Decuman S, Van Praet JT, Deschepper E, Sulli A, Cutolo M.

Ann Rheum Dis. 2010 Jun;69(6):1092-6. doi: 10.1136/ard.2009.115568. Epub 2010 May 3.

PMID:
20439291
30.

Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study.

Smith V, Van Praet JT, Vandooren B, Van der Cruyssen B, Naeyaert JM, Decuman S, Elewaut D, De Keyser F.

Ann Rheum Dis. 2010 Jan;69(1):193-7. doi: 10.1136/ard.2008.095463.

PMID:
19103636

Supplemental Content

Loading ...
Support Center